Volume 59, Issue 4, Pages (April 2001)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Increased expression of heparanase in overt diabetic nephropathy
Jun Wada, Hirofumi Makino, Yashpal S. Kanwar  Kidney International 
Volume 63, Issue 6, Pages (June 2003)
Volume 81, Issue 11, Pages (June 2012)
Volume 65, Issue 2, Pages (February 2004)
Volume 63, Issue 4, Pages (April 2003)
Jun Wada, Hirofumi Makino, Yashpal S. Kanwar  Kidney International 
Volume 61, Issue 2, Pages (February 2002)
Jean-Claude Davin, Ineke J. Ten Berge, Jan J. Weening 
Critical role for osteopontin in diabetic nephropathy
Volume 85, Issue 6, Pages (June 2014)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 69, Issue 10, Pages (May 2006)
Volume 65, Issue 1, Pages (January 2004)
Volume 85, Issue 2, Pages (January 2014)
Hyun Soon Lee, Young Sook Kim  Kidney International 
Screening for genes up-regulated in 5/6 nephrectomized mouse kidney
Volume 63, Issue 6, Pages (June 2003)
Volume 61, Issue 6, Pages (June 2002)
Volume 65, Issue 2, Pages (February 2004)
Volume 77, Issue 11, Pages (June 2010)
Volume 69, Issue 1, Pages (January 2006)
Volume 87, Issue 2, Pages (February 2015)
Volume 58, Issue 5, Pages (November 2000)
Volume 62, Issue 1, Pages (July 2002)
Volume 73, Issue 4, Pages (February 2008)
Volume 70, Issue 8, Pages (October 2006)
Volume 57, Issue 1, Pages (January 2000)
Mohammed S. Razzaque, Ph.D., Takashi Taguchi  Kidney International 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 60, Issue 6, Pages (December 2001)
A meta-analysis of expression signatures in glomerular disease
Oliver Vonend, Clare M. Turner  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Targets to retard the progression of diabetic nephropathy
G.S. Markowitz, C. Gelber, V.D. D'agati  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Volume 67, Issue 2, Pages (February 2005)
The role of protein kinase C activation in diabetic nephropathy
Volume 65, Issue 4, Pages (April 2004)
Volume 58, Issue 6, Pages (December 2000)
A simple method for the specific detection of Ren-1 renin
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 68, Issue 1, Pages (July 2005)
Volume 53, Issue 5, Pages (May 1998)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 62, Issue 5, Pages (November 2002)
Volume 53, Issue 4, Pages (April 1998)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
Volume 63, Issue 4, Pages (April 2003)
Hypertension, race, and glomeruli: more than simply a numbers game
Volume 59, Issue 4, Pages (April 2001)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 66, Issue 5, Pages (November 2004)
Volume 82, Issue 3, Pages (August 2012)
Volume 67, Issue 3, Pages (March 2005)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Volume 57, Issue 5, Pages (May 2000)
Volume 58, Issue 4, Pages (October 2000)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 58, Issue 3, Pages (September 2000)
Volume 75, Issue 5, Pages (March 2009)
Volume 65, Issue 6, Pages (June 2004)
Volume 53, Issue 5, Pages (May 1998)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Jun Wada, Hirofumi Makino, Yashpal S. Kanwar  Kidney International 
Accepting prospective kidney donors with asymptomatic urinary abnormalities: Are we shooting in the dark?  N. Vadivel, A. Stankovic, H.G. Rennke, A.K.
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 59, Issue 4, Pages 1363-1373 (April 2001) Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis  Jun Wada, Hong Zhang, Yoshinori Tsuchiyama, Keita Hiragushi, Kazuyuki Hida, Kenichi Shikata, Yashpal S. Kanwar, Hirofumi Makino  Kidney International  Volume 59, Issue 4, Pages 1363-1373 (April 2001) DOI: 10.1046/j.1523-1755.2001.0590041363.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Light micrographs of glomeruli of ICR mice kidney. The glomeruli in unilaterally nephrectomized mouse (UX) show prominent glomerular hypertrophy and minimal accumulation of mesangial matrix. In contrast, streptozotocin (STZ)-induced diabetic ICR mouse (STZ) and STZ mouse with unilateral nephrectomy (STZ-UX) reveal significant glomerular hypertrophy, a marked increase in the mesangial matrix. (PAM, periodic acid silver methenamine stain; bar = 50 μm). Kidney International 2001 59, 1363-1373DOI: (10.1046/j.1523-1755.2001.0590041363.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Morphometric analyzes of glomeruli of mice kidney. Area of the glomerulus and mesangium are measured with image analysis software OPTIMAS version 6.5. The glomerular size is increased in UX, STZ, and STZ-UX mice, while mesangial matrix only in STZ and STZ-UX mice compared with the controls. Abbreviations are: CON, control ICR mice; UX, unilaterally nephrectomized mice; STZ, streptozotocin (STZ)-induced diabetic mice; STZ-UX, STZ-induced diabetic mice with UX. Kidney International 2001 59, 1363-1373DOI: (10.1046/j.1523-1755.2001.0590041363.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Low (A) and high (B) magnification electron micrographs of the glomerulus from STZ-induced diabetic mouse. An expansion of the mesangial matrix and the narrowing of capillary lumens, similar to human diabetic nephropathy, is observed. (A, bar = 50 μm; B, bar = 20 μm). Kidney International 2001 59, 1363-1373DOI: (10.1046/j.1523-1755.2001.0590041363.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Comparison of gene expression profile of control and streptozotocin (STZ)-induced diabetic kidney by high-density DNA array. The mRNA of control and STZ mouse kidneys was extracted, radiolabeled with [α-33P]dCTP, and hybridized with Gene Discovery Array (GDA) Mouse version 1.1. About one sixth of the total filter area of control (CON) and STZ-induced diabetic (STZ) kidneys is shown. In each corner, the intense hybridization spots of DNA orientation markers are observed. All clones are double spotted to negate the false hybridization signals or high background. The genes with a spot to spot ratio greater than five was selected by Genome Discovery Software. Since the “blooming” action of positive hybridization signals into adjacent wells is observed, spots of the screened genes are visually inspected. Kidney International 2001 59, 1363-1373DOI: (10.1046/j.1523-1755.2001.0590041363.x) Copyright © 2001 International Society of Nephrology Terms and Conditions